Clinicians using one vendor's algorithm found lung squamous cell carcinoma misdiagnoses, influencing treatment decisions and ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...
DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data generated using its ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...
Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...
Five poster presentations span lung cancer early detection, immunotherapy response prediction, cancer subtyping, treatment monitoring, and next-generation ...
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various ...
Abstract: The Lung cancer remains to abundant as a leading reason of cancer-associated death worldwide, which necessitates early recognition for increasing survival rates. Standard diagnostic ...
Researchers identify gene activity patterns linked to vascular invasion in lung cancer, enabling biopsy-based prediction of aggressive tumors, improving treatment decisions and recurrence risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results